HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities
about
Structural basis for NKG2A/CD94 recognition of HLA-E.Activation of NK cells by an endocytosed receptor for soluble HLA-G.Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide AnalysesThermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease associationThe Structure and Stability of the Monomorphic HLA-G Are Influenced by the Nature of the Bound PeptideCharacteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious DiseasesHLA-F complex without peptide binds to MHC class I protein in the open conformer form.The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defectsNonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulumStructural basis for a major histocompatibility complex class Ib-restricted T cell responseMycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activityMHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation.HLA Class Ib Molecules and Immune Cells in Pregnancy and PreeclampsiaNK cells, innate immunity and hepatitis C infection after liver transplantation.HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.Natural polymorphisms in Tap2 influence negative selection and CD4∶CD8 lineage commitment in the ratHuman CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancerNatural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18Glances in Immunology of HIV and HCV InfectionHuman Leukocyte Antigen-E Alleles are Associated with Hepatitis C Virus, Torque Teno Virus, and Toxoplasma Co-infections but are not Associated with Hepatitis B Virus, Hepatitis D Virus, and GB Virus C Co-infections in Human Immunodeficiency Virus PNKG2C deletion is a risk factor of HIV infection.The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.Increased HLA-E expression in white matter lesions in multiple sclerosis.HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral loadBroadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.Association between HLA-E gene polymorphism and unexplained recurrent spontaneous abortion (RSA) in Iranian women.Class I HLA haplotypes form two schools that educate NK cells in different ways.Clinical significance of the HLA-E and CD94/NKG2 interaction.Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?HLA-E: a novel player for histocompatibility.Clinical and immunological significance of HLA-E in stem cell transplantation and cancer.A bird's eye view of NK cell receptor interactions with their MHC class I ligands.Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.HLA class Ib in pregnancy and pregnancy-related disorders.
P2860
Q24336854-04C84622-38D0-464C-B385-BB9FA944AAEDQ24813830-4DA8508F-5E95-42FC-98DF-C6A61701C884Q27027110-5D3DFC81-5BCD-467A-B014-A37E034D2B75Q27642338-056EBA0F-27CF-4E2F-BD4D-C16F6892C13BQ27659367-D738B4F2-4181-46F1-A4A4-222B94EFA6EFQ28079186-9DA84846-1F07-4F21-BAD0-8D0AB417EF01Q28282824-818AE059-934C-4881-B713-A228A13BF288Q28512131-AB9902FA-8542-4471-BBF3-A76B55472B55Q28941251-1921ACAF-BFAE-49CD-920C-D4C96198D9F7Q28941762-B18ACCCC-4EAF-4306-A969-5113FDC06DD7Q33535876-31DDE0EC-1DD1-4868-83CA-FD31E73CFC59Q33699588-EE47AB33-F65B-47D0-9C3F-62E466BB4A0DQ33927547-0BEE4080-5366-4455-BF20-CE08EC176E57Q34506165-0C82E818-97A6-4CB5-AFA7-940187965F88Q34763454-3EC5F2AA-6A36-49A2-B877-DDED9BDD222EQ35019869-F95A2DD9-2464-4718-90D2-95C6DB1027EEQ35081677-D754675F-B677-42EF-9C13-5EECF5C9839DQ35105729-D2232CEE-854C-4609-AEF7-378EAEAB1FAAQ35214233-04785848-009B-4BE2-8110-EFA5A3C80D57Q35674162-6116C06D-DF63-4089-A130-88FC476615D0Q35678024-0228CD11-CCE6-46F8-814A-E29D92DCC0CCQ35742269-68E4D8AA-A90E-4837-A38A-BD0DE54A3879Q35828380-911A46A1-81E0-4C62-88AE-069F85F0E873Q36032051-77B9D3BF-F4F5-44CC-A317-EA4FA603A978Q36049911-EAB96913-6D89-421A-9FB3-8D206C7326E1Q36102561-400848B8-629D-4025-BF2D-DE976E13E145Q36431461-3C1DC554-DADC-4ED0-A7A5-22C15FB7FC3DQ36488406-A5EDBF41-5331-46C4-96B3-C36FE031D4E4Q36606569-3B700A11-D19B-4443-A094-A6F23C80F405Q36624194-7A1B037E-AD1A-4B82-BC58-919193861E9CQ36708679-90907825-20F5-412B-A34B-B86C4A567DD0Q37148130-1AC192A1-AEF4-4F9E-BF66-30D5F54C97B7Q37415636-FAF1AF64-E759-46A6-8E6E-043CD5172760Q37907929-8B5713BB-FE12-4BE3-856E-954CA090682BQ38009207-A2B4D622-CD9B-4334-BA6D-0766AC950347Q38268679-DDD00B1B-D77D-4652-9A86-84224E50A429Q38270003-81B60F02-2AE3-4B95-B075-4CB12A0D6D4CQ38568874-E67C9B9E-2148-4DF8-9E15-94813B2BAA0CQ38585054-3546754B-DCB8-4B79-A81C-139CB3B4B6AFQ38683065-198E96E8-C298-4AC0-83DD-BDD293C25F40
P2860
HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@ast
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en-gb
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@nl
type
label
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@ast
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en-gb
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@nl
prefLabel
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@ast
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en-gb
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@nl
P2093
P2860
P3181
P356
P1476
HLA-E allelic variants. Correl ...... tures, and thermal stabilities
@en
P2093
Daniel E Geraghty
Laura Braun
Margaret A Holmes
Pingwei Li
Roland K Strong
P2860
P304
P3181
P356
10.1074/JBC.M208268200
P407
P577
2003-02-14T00:00:00Z